Arax Advisory Partners’s Encompass Health EHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $249K | Sell |
2,027
-1,805
| -47% | -$221K | 0.01% | 582 |
|
|
2025
Q1 | $388K | Buy |
3,832
+2,912
| +317% | +$295K | 0.02% | 363 |
|
|
2024
Q4 | $85K | Sell |
920
-15
| -2% | -$1.39K | 0.01% | 731 |
|
|
2024
Q3 | $90.3K | Buy |
935
+116
| +14% | +$11.2K | 0.01% | 524 |
|
|
2024
Q2 | $70.2K | Buy |
819
+155
| +23% | +$13.3K | 0.01% | 555 |
|
|
2024
Q1 | $54.8K | Sell |
664
-1
| -0.2% | -$83 | 0.01% | 481 |
|
|
2023
Q4 | $44.3K | Buy |
665
+489
| +278% | +$32.6K | ﹤0.01% | 503 |
|
|
2023
Q3 | $11.8K | Buy |
176
+68
| +63% | +$4.58K | ﹤0.01% | 683 |
|
|
2023
Q2 | $7.33K | Buy |
108
+33
| +44% | +$2.24K | ﹤0.01% | 776 |
|
|
2023
Q1 | $4.07K | Sell |
75
-19
| -20% | -$1.03K | ﹤0.01% | 892 |
|
|
2022
Q4 | $5.63K | Sell |
94
-15
| -14% | -$899 | ﹤0.01% | 764 |
|
|
2022
Q3 | $5K | Sell |
109
-28
| -20% | -$1.28K | ﹤0.01% | 791 |
|
|
2022
Q2 | $6K | Hold |
137
| – | – | ﹤0.01% | 730 |
|
|
2022
Q1 | $8K | Buy |
137
+35
| +34% | +$2.04K | ﹤0.01% | 683 |
|
|
2021
Q4 | $5K | Sell |
102
-35
| -26% | -$1.72K | ﹤0.01% | 757 |
|
|
2021
Q3 | $8K | Hold |
137
| – | – | ﹤0.01% | 679 |
|
|
2021
Q2 | $9K | Buy |
+137
| New | +$9K | ﹤0.01% | 676 |
|